Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Forward Genetic Screen in Caenorhabditis elegans Suggests F57A10.2 and acp-4 As Suppressors of C9ORF72 Related Phenotypes.

Wang X, Hao L, Saur T, Joyal K, Zhao Y, Zhai D, Li J, Pribadi M, Coppola G, Cohen BM, Buttner EA.

Front Mol Neurosci. 2016 Nov 8;9:113.

2.

Why Quantification Matters: Characterization of Phenotypes at the Drosophila Larval Neuromuscular Junction.

Sanhueza M, Kubasik-Thayil A, Pennetta G.

J Vis Exp. 2016 May 12;(111). doi: 10.3791/53821.

3.
4.

Insights into ALS pathomechanisms: from flies to humans.

Chai A, Pennetta G.

Fly (Austin). 2015;9(2):91-8. doi: 10.1080/19336934.2015.1114694.

5.

Drosophila as an In Vivo Model for Human Neurodegenerative Disease.

McGurk L, Berson A, Bonini NM.

Genetics. 2015 Oct;201(2):377-402. doi: 10.1534/genetics.115.179457. Review.

6.

A systematic screening to identify de novo mutations causing sporadic early-onset Parkinson's disease.

Kun-Rodrigues C, Ganos C, Guerreiro R, Schneider SA, Schulte C, Lesage S, Darwent L, Holmans P, Singleton A; International Parkinson's Disease Genomics Consortium (IPDGC)., Bhatia K, Bras J.

Hum Mol Genet. 2015 Dec 1;24(23):6711-20. doi: 10.1093/hmg/ddv376.

7.

Autophagy and Neurodegeneration: Insights from a Cultured Cell Model of ALS.

Navone F, Genevini P, Borgese N.

Cells. 2015 Aug 6;4(3):354-86. doi: 10.3390/cells4030354. Review.

8.

Network analyses reveal novel aspects of ALS pathogenesis.

Sanhueza M, Chai A, Smith C, McCray BA, Simpson TI, Taylor JP, Pennetta G.

PLoS Genet. 2015 Mar 31;11(3):e1005107. doi: 10.1371/journal.pgen.1005107.

9.

Amyotrophic lateral sclerosis-linked mutant VAPB inclusions do not interfere with protein degradation pathways or intracellular transport in a cultured cell model.

Genevini P, Papiani G, Ruggiano A, Cantoni L, Navone F, Borgese N.

PLoS One. 2014 Nov 19;9(11):e113416. doi: 10.1371/journal.pone.0113416.

10.

A genetic screen identifies Tor as an interactor of VAPB in a Drosophila model of amyotrophic lateral sclerosis.

Deivasigamani S, Verma HK, Ueda R, Ratnaparkhi A, Ratnaparkhi GS.

Biol Open. 2014 Oct 31;3(11):1127-38. doi: 10.1242/bio.201410066.

11.

A fruitful endeavor: modeling ALS in the fruit fly.

Casci I, Pandey UB.

Brain Res. 2015 May 14;1607:47-74. doi: 10.1016/j.brainres.2014.09.064. Review.

12.

Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies.

Peeters K, Chamova T, Jordanova A.

Brain. 2014 Nov;137(Pt 11):2879-96. doi: 10.1093/brain/awu169. Review.

13.

VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase.

Baron Y, Pedrioli PG, Tyagi K, Johnson C, Wood NT, Fountaine D, Wightman M, Alexandru G.

BMC Biol. 2014 May 29;12:39. doi: 10.1186/1741-7007-12-39.

14.

Gain-of-function mutations in the ALS8 causative gene VAPB have detrimental effects on neurons and muscles.

Sanhueza M, Zechini L, Gillespie T, Pennetta G.

Biol Open. 2014 Jan 15;3(1):59-71. doi: 10.1242/bio.20137070.

15.

Amyotrophic lateral sclerosis (ALS)-associated VAPB-P56S inclusions represent an ER quality control compartment.

Kuijpers M, van Dis V, Haasdijk ED, Harterink M, Vocking K, Post JA, Scheper W, Hoogenraad CC, Jaarsma D.

Acta Neuropathol Commun. 2013 Jun 12;1:24. doi: 10.1186/2051-5960-1-24.

16.

Clinical neurogenetics: amyotrophic lateral sclerosis.

Harms MB, Baloh RH.

Neurol Clin. 2013 Nov;31(4):929-50. doi: 10.1016/j.ncl.2013.05.003. Review.

17.

VAPB/ALS8 MSP ligands regulate striated muscle energy metabolism critical for adult survival in caenorhabditis elegans.

Han SM, El Oussini H, Scekic-Zahirovic J, Vibbert J, Cottee P, Prasain JK, Bellen HJ, Dupuis L, Miller MA.

PLoS Genet. 2013;9(9):e1003738. doi: 10.1371/journal.pgen.1003738.

18.

Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB.

Kwok CT, Morris A, de Belleroche JS.

Eur J Hum Genet. 2014 Apr;22(4):492-6. doi: 10.1038/ejhg.2013.184.

19.

Genetics of amyotrophic lateral sclerosis: an update.

Chen S, Sayana P, Zhang X, Le W.

Mol Neurodegener. 2013 Aug 13;8:28. doi: 10.1186/1750-1326-8-28. Review.

20.

Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.

Ling SC, Polymenidou M, Cleveland DW.

Neuron. 2013 Aug 7;79(3):416-38. doi: 10.1016/j.neuron.2013.07.033. Review.

Supplemental Content

Support Center